Pfizer moves forward with once-daily weight-loss pill to compete with Wegovy
Pfizer, which discontinued a twice-daily version of the drug late last year, said Thursday that an improved, once-daily version of its weight-loss drug danugliplon will move into clinical trials later this year. The new drug is one of a generation of second-generation weight-loss drugs being developed by companies including Eli Lilly and Novo Nordisk that […]
